Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,979 | -186,479 | -121,546 | -74,118 | -30,717 |
| Depreciation Amortization | 2,767 | 8,405 | 6,169 | 3,733 | 1,402 |
| Accounts receivable | -7,551 | N/A | -6,746 | -2,362 | -2,830 |
| Accounts payable and accrued liabilities | 1,344 | 1,745 | 5,252 | 2,122 | 2,051 |
| Other Working Capital | 122,824 | -306 | 3,653 | -3,637 | -4,630 |
| Other Operating Activity | 13,983 | 18,021 | 15,762 | 9,854 | 3,969 |
| Operating Cash Flow | $77,388 | $-158,614 | $-97,456 | $-64,408 | $-30,755 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 147,646 | -231,946 | -184,167 | N/A | N/A |
| PPE Investments | -4,342 | -39,798 | -35,334 | -25,628 | -19,416 |
| Investing Cash Flow | $143,304 | $-271,744 | $-219,501 | $-25,628 | $-19,416 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -22 | -12,798 | -12,777 | -40 | -20 |
| Common Stock Issued | N/A | 462,901 | 462,901 | 462,901 | N/A |
| Other Financing Activity | 2,106 | 8,437 | 4,620 | 2,978 | 2,154 |
| Financing Cash Flow | $2,084 | $458,540 | $454,744 | $465,839 | $2,134 |
| Beginning Cash Position | 295,349 | 267,167 | 267,167 | 267,167 | 267,167 |
| End Cash Position | 518,125 | 295,349 | 404,954 | 642,970 | 219,130 |
| Net Cash Flow | $222,776 | $28,182 | $137,787 | $375,803 | $-48,037 |
| Free Cash Flow | |||||
| Operating Cash Flow | 77,388 | -158,614 | -97,456 | -64,408 | -30,755 |
| Capital Expenditure | -4,342 | -39,798 | -35,334 | -25,628 | -19,416 |
| Free Cash Flow | 73,046 | -198,412 | -132,790 | -90,036 | -50,171 |